Studies by Mujahid and co-workers have demonstrated that mutations in the BBS1 gene are associated with the most severe clinical manifestations of metabolic dysfunction in BBS patients, including obesity, insulin resistance, and dyslipidemia [7]. Here, BBS1 is linked to obesity due to melanocortin 4 receptor deficiency.